Full-Time
Technical Product Manager
Multiple Teams
Posted on 11/15/2025
Ottobock
1,001-5,000 employees
Provider of prosthetics, orthotics, wheelchairs, exoskeletons
No salary listed
Germany + 1 more
More locations: Berlin, Germany
Remote
 Product (1) |
|---|
- Minimum 3 years of professional experience in IT product and/or application management, preferably in a marketing, sales, or eCommerce environment.
- Hands-on experience with PIM systems is required, preferably with Pimcore.
- Solid understanding of PIM/MAM concepts and data structures.
- Strong proven (agile) project management skills with a structured, transparent, and collaborative working style.
- Fluent in German and English
- Drive within the team the technical management and continuous development of our Pimcore-based PIM/MAM system
- Configure and implement new features within Pimcore to meet evolving business needs
- Ensure seamless integration of the PIM/MAM with eCommerce, assortment management, and content delivery workflows
- Collaborate closely with marketing, eCommerce, product management, and external stakeholders to gather requirements and deliver solutions
- Manage projects end-to-end with structured planning, clear documentation, and transparent communication
- Act as the key liaison between IT and business teams to ensure technical feasibility and alignment with business goals
Ottobock is a global producer of orthopedic technology, focusing on prosthetics, orthotics, wheelchairs, and exoskeletons. Its products range from basic devices to advanced, microprocessor-controlled prosthetics and ergonomic exoskeletons that help people move more easily and stay independent. These devices work by using sensors, motors, and smart controls to adapt to a user’s movement, pace, and terrain, providing ankle and knee assistance or full upper- and lower-limb support. compared with others, Ottobock stands out as a family-owned company with a long history, a broad international footprint in about 60 countries, a large workforce, and a strong commitment to social responsibility, including a long-running partnership with the Paralympic Games. Its core goal is to improve mobility and quality of life for people with disabilities by delivering reliable, high-quality mobility solutions.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Duderstadt, Germany
Founded
1919
Simplify's Take
What believers are saying
- IPO raised €702-808M in October 2025, shares surged 11% to €73.
- $5M Blue Arbor investment advances FDA breakthrough RESTORE system.
- SuitX acquisition in 2021 expands exoskeletons into industrial markets.
What critics are saying
- Össur's POWER KNEE erodes C-Leg share by 15% via AI gait prediction.
- Deren Bionics captures 25% Asia-Pacific orthotics with cheaper prosthetics.
- Näder family succession dispute forces share sales, crashing stock 25-40%.
What makes Ottobock unique
- Ottobock leads globally in prosthetics as world market leader since 1919.
- Advanced microprocessor prosthetics like C-Leg set industry benchmarks.
- Long-term Paralympic partnership drives mobility innovation worldwide.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Company Match
100% company-paid short & long-term disability
Company News
Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.
Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control
Onward has completed its capital round, securing €50.85 million from a group of major investors.
Ottobock SE & Co. KGaA shares have been stabilizing since their IPO on October 14, with trading starting at €66.00. The lowest price reached was €64.50 on October 17. Stabilization measures, managed by Goldman Sachs Bank Europe SE, have been conducted daily across multiple trading venues, including XETRA and the Frankfurt Stock Exchange. The base offering included 10,640,151 shares. The shares are trading under ISIN DE000BCK2223.
Ottobock SE & Co. shares rose in the prosthetics firm’s debut trading session in Frankfurt on Thursday, after the biggest initial public offering in Germany in more than a year.